Gene · 4600
Papers2,393
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,393
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Heterogeneity in inflammatory responses to endotoxin at the fetomaternal interface. | J Immunol | 2026 | 41847862 | PubTator, text mining | PubMed |
| Human iPSC-derived airway models enable comparative analysis of SARS-CoV-2 infection in healthy and COPD bronchial epithelium. | iScience | 2026 | 41782833 | PubTator, text mining | PubMed |
| Evaluating the Diagnostic Potential of Myxovirus Resistance Protein 1 (MX1) and Myxovirus Resistance Protein 2 (MX2) As Biomarkers in Idiopathic Inflammatory Myopathies. | Cureus | 2026 | 41769532 | PubTator, text mining | PubMed |
| Microglial heterogeneity: influence of human 2D, 3D, and co-culture models on gene expression and immune function. | Front Cell Neurosci | 2026 | 41757348 | PubTator, text mining | PubMed |
| Antiviral Inflammasomes and How to Find Them. | Viruses | 2026 | 41754516 | PubTator, text mining | PubMed |
| Protease Inhibitors and Innate Immune Agonists as Antiviral Strategies Against Dengue and Zika Viruses. | Pathogens | 2026 | 41754484 | PubTator, text mining | PubMed |
| Human serum influences functional plasticity and transcriptomic landscape of γδ T cells in vitro. | Front Immunol | 2026 | 41743736 | PubTator, text mining | PubMed |
| Impact of adjuvants on a recombinant SARS-CoV-2 spike vaccine: Protective efficacy and recall antibody response following homologous challenge. | Biosaf Health | 2026 | 41743023 | PubTator, text mining | PubMed |
| Dose-dependent IFN programs in myeloid cells after mRNA and adenovirus COVID-19 vaccination. | JCI Insight | 2026 | 41729080 | PubTator, text mining | PubMed |
| microRNA-422a promotes HIV replication and innate immune evasion by targeting MECP2. | Mol Ther Nucleic Acids | 2026 | 41717286 | PubTator, text mining | PubMed |
| Interferon-Driven Tryptophan Metabolism Links Inflammation and Mental Health in Juvenile Dermatomyositis. | Inflammation | 2026 | 41708553 | PubTator, text mining | PubMed |
| Nuclear import of malaria RNA rewires splicing in host immune cells. | Cell Rep | 2026 | 41689806 | PubTator, text mining | PubMed |
| Spatial proteomics reveals layer-specific molecular landscapes and keratin 17-mediated inflammatory crosstalk in oral lichen planus of the tongue. | Br J Dermatol | 2026 | 41640051 | PubTator, text mining | PubMed |
| The host protein cyclophilin A restricts nuclear entry of HIV-1 mutants by reducing the elasticity of the viral capsid. | PLoS Pathog | 2026 | 41610155 | PubTator, text mining | PubMed |
| The shared biomarkers and molecular mechanisms of systemic lupus erythematosus and type 2 diabetes. | PLoS One | 2026 | 41569989 | PubTator, text mining | PubMed |
| Exploration of shared gene signatures and molecular mechanisms between psoriasis and COVID-19: evidence from transcriptome data. | Mamm Genome | 2026 | 41530290 | PubTator, text mining | PubMed |
| IRF1 suppresses gastric tumorigenesis via dual PI3K/AKT-ERK pathway modulation and functional antagonism of oncogenic MX2. | Cell Oncol (Dordr) | 2026 | 41528639 | PubTator, text mining | PubMed |
| Cell type-specific interactions induce tonic interferon production in endothelial cells in a pathogen-independent manner. | Cell Commun Signal | 2026 | 41527090 | PubTator, text mining | PubMed |
| Protective effects of Prunella vulgaris polysaccharides against herpes simplex virus type 1 infection through the STING-TBK1-IRF3 pathway. | J Integr Med | 2026 | 41506946 | PubTator, text mining | PubMed |
| A first-principles theoretical study on two-dimensional MX and MX2 metal halides: bandgap engineering, magnetism, and catalytic descriptors. | Phys Chem Chem Phys | 2026 | 41479280 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4600/papers?page=2